Atlas Trials

Open Multicenter Study for Assessment of Efficacy and Safety of Molnupiravir in Adult Patients With COVID-19

Clinical trial NCT05595824 · COMPLETED

Trial details

NCT number
NCT05595824
Sponsor
Promomed, LLC
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
COVID-19
Start date
2021-12-01
Primary completion
2022-03-11
Enrollment
240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.